As GLP-1 drugs make home-administered jabs commonplace, others in the wellness space are adopting the method ...
Jonathan Wolfson is a visiting fellow at the Institute for the American Worker. He headed the Labor Department’s policy office in the first Trump administration. Millions of American workers are on ...
Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...
Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...
Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health ...
While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...
People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...
Background Supervised injecting facilities (SIFs) are designed to reduce the harms associated with injecting drug use and improve access to health and support services for people who need them. The ...
So far, the most headline-making Olympic news has nothing to do with gold medals. But rather, what some male Olympians are willing to do for them. Enter: Penisgate. Mere days after the Olympics began, ...
Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...
When Lindsey Boynton was offered the option to give herself her birth control shot at home, she was surprised the option even existed. The method — self-injected subcutaneous depot medroxyprogesterone ...
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...